{
    "clinical_study": {
        "@rank": "166591", 
        "arm_group": {
            "arm_group_label": "Tamsulosin", 
            "arm_group_type": "Experimental", 
            "description": "The dosage form of Tamsulosin is tablet, dosage is 0.2mg, frequency is once daily and duration is 6 months."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether medical treatment for bladder outlet\n      obstruction is effective in improvement of glomerular filtration rate and/or proteinuria."
        }, 
        "brief_title": "The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chronic Kidney Failure", 
            "Prostatic Hyperplasia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Prostatic Hyperplasia", 
                "Hyperplasia", 
                "Kidney Failure, Chronic", 
                "Renal Insufficiency"
            ]
        }, 
        "detailed_description": {
            "textblock": "Urodynamic parameters including maximal flow rate, compliance (infused volume gradient\n      divided by bladder pressure gradient during cystometry), maximal detrusor pressure, bladder\n      outlet obstruction index and Sch\u00e4fer grade will be checked.\n\n      Estimated glomerular filtration rate and urinary protein to creatinine ratio will be\n      checked.\n\n      International prostate symptom score will be checked."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Men with low urinary tract symptoms aged between 40 and 80\n\n          -  Estimated glomerular filtration rate < 60 or evidence of proteinuria\n\n          -  Bladder outlet obstruction index > 40, Sch\u00e4fer  grade 2 or more, maximal flow rate\n             lower than 10 cc/s or postvoid residual urine > 100cc\n\n        Exclusion Criteria:\n\n          -  Bladder outlet obstruction index less than 40, Sch\u00e4fer  grade 0 or 1, maximal flow\n             rate higher than 10 ml/s and postvoid residual urine less than 100cc\n\n          -  Want surgical procedure\n\n          -  Evidence of prostate cancer or bladder cancer\n\n          -  Major depressive disorder, Dementia, Parkinson's disease or neurological deficits\n\n          -  History of pelvic irradiation\n\n          -  Uncontrolled diabetes mellitus or hypertension\n\n          -  Symptomatic orthostatic hypotension"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "34", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02033798", 
            "org_study_id": "L201401N2"
        }, 
        "intervention": {
            "arm_group_label": "Tamsulosin", 
            "description": "Once Daily 0.2mg per oral for 6 months", 
            "intervention_name": "Tamsulosin", 
            "intervention_type": "Drug", 
            "other_name": [
                "Harnal D", 
                "Tamsnal"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Tamsulosin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Urodynamics", 
            "Glomerular Filtration Rate"
        ], 
        "lastchanged_date": "January 15, 2014", 
        "location": {
            "contact": {
                "email": "lee.seungju@gmail.com", 
                "last_name": "Seung-Ju Lee Lee, MD, PhD", 
                "phone": "82-31-249-8305"
            }, 
            "facility": {
                "address": {
                    "city": "Suwon", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "442-723"
                }, 
                "name": "St. Vincent's Hospital"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Impact of Medical Treatment for Benign Prostatic Hyperplasia on Chronic Renal Failure", 
        "other_outcome": {
            "measure": "International prostate symptom score", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "overall_contact": {
            "email": "lee.seungju@gmail.com", 
            "last_name": "Seung-Ju Lee, MD, PhD", 
            "phone": "82-31-249-8305"
        }, 
        "overall_contact_backup": {
            "email": "lds@catholic.ac.kr", 
            "last_name": "Dong Sup Lee, MD, PhD", 
            "phone": "82-31-249-8276"
        }, 
        "overall_official": [
            {
                "affiliation": "The Catholic University of Korea", 
                "last_name": "Seung-Ju Lee, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "The Catholic University of Korea", 
                "last_name": "Dong Sup Lee, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "This parameter can be obtained from urodynamic study.", 
                "measure": "Maximal flow rate", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "This parameter can be obtained from urodynamic study.", 
                "measure": "Maximal detrusor pressure", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "This parameter can be obtained from urodynamic study.", 
                "measure": "Bladder outlet obstruction index", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "This parameter can be obtained from urodynamic study.", 
                "measure": "sch\u00e4fer grade", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "This parameter can be obtained from urodynamic study.", 
                "measure": "Compliance", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02033798"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Catholic University of Korea", 
            "investigator_full_name": "Seung-Ju Lee", 
            "investigator_title": "Senior researcher", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Estimated glomerular filtration rate", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Urinary protein to creatinine ratio", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "The Catholic University of Korea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Catholic University of Korea", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}